Drug
Gemcitabine
Gemcitabine: highest development phase Approved, developed by Amgen, Eli Lilly, Hansoh Pharmaceutical and others. 4 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Amgen, Eli Lilly, Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| GEMCITABINE HYDROCHLORIDE | Approved | |
| Gemcitabine NCT00613730 | Phase 2 | Cancer of Pancreas |
| gemcitabine NCT00489996 | Phase 2 | Non-Small Cell Lung Cancer |
| Gemcitabine NCT03316599 | Phase 1 | Pancreatic Cancer |
Latest
No recent events.
Follow Gemcitabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.